ZA201100635B - Sustained release pharmaceutical compositions comprising quetiapine - Google Patents

Sustained release pharmaceutical compositions comprising quetiapine

Info

Publication number
ZA201100635B
ZA201100635B ZA2011/00635A ZA201100635A ZA201100635B ZA 201100635 B ZA201100635 B ZA 201100635B ZA 2011/00635 A ZA2011/00635 A ZA 2011/00635A ZA 201100635 A ZA201100635 A ZA 201100635A ZA 201100635 B ZA201100635 B ZA 201100635B
Authority
ZA
South Africa
Prior art keywords
quetiapine
pharmaceutical compositions
sustained release
release pharmaceutical
sustained
Prior art date
Application number
ZA2011/00635A
Other languages
English (en)
Inventor
Avinash Krishnaji Velhal
Sunil Anantrao Mirajkar
Virendra Ramkrupal Kuril
Vineeth Raghavan
Ninad Deshpanday
Original Assignee
Lupin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lupin Ltd filed Critical Lupin Ltd
Publication of ZA201100635B publication Critical patent/ZA201100635B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA2011/00635A 2008-07-01 2011-01-25 Sustained release pharmaceutical compositions comprising quetiapine ZA201100635B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1143KO2008 2008-07-01
PCT/IN2009/000369 WO2010001413A2 (en) 2008-07-01 2009-06-29 Sustained release pharmaceutical compositions comprising quetiapine

Publications (1)

Publication Number Publication Date
ZA201100635B true ZA201100635B (en) 2011-10-26

Family

ID=40957738

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2011/00635A ZA201100635B (en) 2008-07-01 2011-01-25 Sustained release pharmaceutical compositions comprising quetiapine

Country Status (6)

Country Link
US (1) US8440223B2 (enExample)
EP (1) EP2309994A2 (enExample)
JP (2) JP2011526622A (enExample)
AU (1) AU2009265099A1 (enExample)
WO (1) WO2010001413A2 (enExample)
ZA (1) ZA201100635B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011154118A1 (en) 2010-06-07 2011-12-15 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Quetiapine prolonged-release tablets
TR201104977A1 (tr) 2011-05-23 2012-12-21 Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ Kontrollü salım gerçekleştiren kaplamaya sahip ketiapin formülasyonu.
DE102011115690A1 (de) 2011-10-11 2013-04-11 Acino Pharma Ag Quetiapin enthaltende Formulierungen
WO2013095312A1 (en) * 2011-12-19 2013-06-27 Mahmut Bilgic Formulations comprising quetiapine fumarate
US20150231080A1 (en) * 2012-09-10 2015-08-20 Pharmathen S.A. Pharmaceutical composition comprising an atypical antipsychotic agent and method for the preparation thereof
WO2014155387A1 (en) * 2013-03-24 2014-10-02 Tushar Patel Extended release dosage forms of quetiapine salts
EP2848244A1 (en) 2013-09-16 2015-03-18 Yildiz Özsoy Erginer Extended release tablet formulations of quetiapine
CN104523600A (zh) * 2014-11-21 2015-04-22 哈尔滨圣吉药业股份有限公司 一种富马酸喹硫平缓释微丸及其制备方法
US9993486B1 (en) 2017-06-19 2018-06-12 Tlc Therapeutics, Llc Oral quetiapine suspension formulations with extended shelf life and enhanced bioavailability

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607684D0 (en) 1986-03-27 1986-04-30 Ici America Inc Thiazepine compounds
JPH0658877A (ja) * 1992-08-11 1994-03-04 Daicel Chem Ind Ltd 酢酸セルロース中のゲル量の評価方法
JP2006219502A (ja) * 1994-04-22 2006-08-24 Astellas Pharma Inc 結腸特異的薬物放出システム
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
NZ513037A (en) * 1999-01-29 2003-05-30 Disphar Internat B Coated sustained release pharmaceutical composition for the release of an agent in the gastrointestinal tract
JP2007509155A (ja) * 2003-10-21 2007-04-12 アルファーマ インコーポレイテッド クエチアピンを含有する薬剤
CN101212958A (zh) 2005-06-29 2008-07-02 万能药生物有限公司 基于两种聚合物的控释药物组合物及其制备方法
EP2457563B1 (en) 2006-05-09 2017-03-22 Mallinckrodt LLC Zero-order modified release solid dosage forms
EP2114380A1 (en) * 2007-01-25 2009-11-11 Panacea Biotec Ltd. Modified release pharmaceutical composition and a process of making the same
US20110052648A1 (en) * 2008-03-12 2011-03-03 Avi Avramoff Oral modified-release formulations containing thiazepines
US7794750B2 (en) 2008-06-20 2010-09-14 Mutual Pharmaceutical Company, Inc. Controlled-release formulations, method of manufacture, and use thereof
SI2262486T1 (sl) * 2008-08-01 2013-04-30 Krka, Tovarna Zdravil, D.D., Novo Mesto Sestavek kvetiapina

Also Published As

Publication number Publication date
US20110151002A1 (en) 2011-06-23
US8440223B2 (en) 2013-05-14
JP2014196334A (ja) 2014-10-16
WO2010001413A2 (en) 2010-01-07
AU2009265099A1 (en) 2010-01-07
JP2011526622A (ja) 2011-10-13
EP2309994A2 (en) 2011-04-20
WO2010001413A3 (en) 2010-08-12

Similar Documents

Publication Publication Date Title
HUE047394T2 (hu) Nyújtott hatóanyagleadású, poloxamert tartalmazó gyógyászati készítmények
GB0814695D0 (en) Pharmaceutical compositions
IL247741A0 (en) pharmaceutical preparations
PT2323623T (pt) Composições farmacêuticas
ZA201102406B (en) Pharmaceutical composition for modified release
ZA201101198B (en) Pharmaceutical composition
PL2285357T3 (pl) Kompozycja farmaceutyczna zawierająca brivaracetam
EP2222313A4 (en) PHARMACEUTICAL COMPOSITIONS
ZA201100635B (en) Sustained release pharmaceutical compositions comprising quetiapine
ZA200810178B (en) Pharmaceutical compositions for sustained release of phenyephrine
EP2268278A4 (en) PHARMACEUTICAL COMPOSITION
EP2146695A4 (en) PHARMACEUTICAL COMPOSITIONS
GB0707127D0 (en) Pharmaceutical compositions
GB0709811D0 (en) Pharmaceutical compositions
IL206487A0 (en) Pharmaceutical compositions
GB2464200B (en) Pharmaceutical composition
GB0817969D0 (en) Pharmaceutical composition
GB0712454D0 (en) Pharmaceutical compositions
GB2454923B (en) Pharmaceutical compositions
GB0800659D0 (en) Pharmaceutical Compositions
IL201394A0 (en) Niacin - based pharmaceutical compositions
EP2236135A4 (en) STABLE PHARMACEUTICAL COMPOSITION
IL178378A0 (en) Extended release pharmaceutical compositions
HU0700172D0 (en) Sustained release pharmaceutical preparation
GB0806156D0 (en) Pharmaceutical compositions